Therapy for vasodilatory shock: Arginine vasopressin

Seminars in Anesthesia

Volumn 19, Issue 2, 2000, Pages 98-107

  Morales, David L S ^b   Landry, Donald W ^a   Oz, Mehmet C ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ARGIPRESSIN; DOBUTAMINE; DOPAMINE; MILRINONE; NORADRENALIN;

HEMODYNAMICS; HORMONAL THERAPY; HUMAN; HYPOTENSION; PRIORITY JOURNAL; REVIEW; SHOCK; VASODILATATION;

EID: 0033936438     PISSN: 02770326     EISSN: None     Source Type: Journal    
DOI: 10.1053/sa.2000.6789     Document Type: Article

References (37)

1. Argenziano M Chen JM Choudhri AF Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent J Thorac Cardiovasc Surg 116 1998 973 980
2. Landry DW Levin HR Gallant EM Vasopressin deficiency contributes to the vasodilation of septic shock Circulation 95 1997 1122 1125
3. Morales DLS Madigan J Cullinane S Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock Circulation 100 1999 226 229
4. Thiemermann C Szabo C Mitchell A Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide Proc Natl Acad Sci USA 90 1993 267 271
5. + channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog J Clin Invest 89 1992 2071 2074
6. Kilbourn RG Gross SS Jubran A Ng-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide Proc Natl Acad Sci USA 87 1990 3629 3632
7. abstr Argenziano M Choudhri AF Mozami N Vasodilatory hypotension after cardiopulmonary bypass: Risk factors and potential mechanisms Circulation 96 suppl 1 1997 1 680
8. Argenziano M Choudhri AF Oz MC A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement Circulation 96 1997 II286 II290
9. Morales DLS Gregg D Helman DN Arginine vasopressin in the treatment of fity patients with postcardiotomy vasodilatory shock Ann Thorac Surg 69 2000 102 106
10. Landry DW Levin HR Gallant EM Vasopressin pressor hypersensitivity in vasodilatory septic shock Crit Care Med 25 8 1997 1279 1282
11. Hays RM Vasopressin and other agents affecting the renal conservation of water Jackson EK Goodman and Gilman's The Pharmacological Basis of Therapeutics en 9 1996 McGraw-Hill New York 732 742
12. Altura BM Vascular smooth muscle and neurohypophyseal hormones Fed Proc 36 1977 1853 1860
13. Mitchell RH Kirk JC Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin Biochem Soc Trans 7 1979 861 865
14. Morel A O'Carrol AM Brownstein MJ Molecular cloning and expression of a rat Vla arginine vasopressin receptor Nature 356 1992 523 526
15. Howel J Wheatley M Molecular pharmacology of Vla vasopressin receptors Gen Pharmacol 25 1995 1143 1152
16. Howel J Wheatley M Molecular pharmacology of V1a vasopressin receptors Genet Pharmacol 25 1995 1143 1152
17. Tetsuka T Nakaya Y Inoue I Arginine vasopressin inhibits interleukin-1Beta-stimulated nitric oxide and cyclic guanosine monophosphate production via the V1 receptor in culturedrat vascular smooth muscle cells J Hypertens 15 1997 627 632
18. Frajewicki V Kahana L Yecheli H Effects of severe hemorrhage on plasma ANP and glomerular ANP receptors Am J Physiol 273 1997 R1623 R1630
19. Szabo C Salzlman AL Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock Shock 5 1996 391 394
20. atp-channel inhibition improves hemodynamics and cellular energetics in hemorrhagic shock Am J Physiol 272 1997 H688 H694
21. + channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog J Clin Invest 89 1992 2071 2074
22. Grollman A Geiling EMK The cardiovascular and metabolic reactions of man to the intramuscular injection of posterior pituitary liquid (pituitrin), pitressin, and pitocin J Pharmacol Exp Ther 46 1932 447 460
23. Wagner HN Jr Braunwald E The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension J Clin Invest 35 1956 1412 1418
24. Graybiel A Glendy RE Circulatory effects following the intravenous administration of pitressin in normal persons and in patients with hypertension and angina pectoris Am Heart J 21 1941 481 489
25. Padfield PL Brown JJ Lever AF Blood pressure in acute and chronic vasopressin excess N Engl J Med 304 1981 1067 1070
26. Schwartz J Reid IA Effect of vasopressin blockade on blood pressure regulation during hemorrhage in conscious dogs Endocrinology 112 1 1983 234 238
27. Ericsson BF Hemodynamic effect of vasopressin during haemorrhagic hypotension in the anesthetized dog Acta Chir Scand 138 1972 227 233
28. Ericsson BF The effect of vasopressin on the distribution of cardiac output in the early phase of haemorrhagic shock in the anesthetized dog Acta Chir Scand 138 1972 119 123
29. Foreman BW Dai XZ Bache RJ Vasoconstriction of canine coronary collateral vessels with vasopressin limits blood flow to collateral-dependent myocardium during exercise Circ Res 69 1991 657 664
30. Wakim KG Denton C Essex HE Certain cardiovascular effects of vasopressin (pitressin) Am Heart J 47 1954 77
31. Ericsson BP Effect of vasopressin on the distribution of cardiac output and organ blood flow in the anesthetized dog Acta Chir Scand 137 1971 729 738
32. Edward RM Rinza W Kinter LB Renal microvascular effects of vasopressin and vasopressin antagonist Am J Physiol 256 1983 F526 F543
33. Edward RM Segmental effects of norepinephrine and angiotensin II on isolate renal microvessels Am J Physiol 244 1983 F526 F534
34. Wagner HN Jr Braunwald E The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension J Clin Invest 35 1956 1412 1418
35. Davis JO Hartroft PM Titus EO The role of the renin-angiotensin system in the control of aldosterone secretion J Clin Invest 41 1962 378 389
36. Mellander S Lewis David H Effect of hemorrhagic shock on the reactivity of resistance and capacitance vessels and on capillary filtration transfer in cat skeletal muscle Circ Res 13 1963 105 118
37. Errington ML Rocha M The secretion and clearance of vasopressin during the development of irreversible haemorrhagic shock J Physiol 217 1 1971 P43 P45